1,4-dihydropyridine has been researched along with Myocardial Infarction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drowley, L; Eschenhagen, T; Hirt, MN; Längle, D; Plowright, AT; Polla, M; Reckzeh, E; Schade, D; Schaumann, N; Werner, TR; Wesseler, F | 1 |
| Birkenhäger, WH; Bulpitt, CJ; Celis, H; de Leeuw, PW; Fagard, R; Fletcher, AE; Forette, F; Leonetti, G; McCormack, P; Nachev, C; O'Brien, E; Rodicio, JL; Rosenfeld, J; Sarti, C; Staessen, JA; Thijisq, L; Tuomilehto, J; Webster, J; Yodfat, Y; Zanchetti, A | 1 |
| Gao, X; Gillman, MW; Goldman, L; Hertzmark, E; McLaughlin, TJ; Ross-Degnan, D; Soumerai, SB; Spiegelman, D | 1 |
1 trial(s) available for 1,4-dihydropyridine and Myocardial Infarction
| Article | Year |
|---|---|
Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus; Dihydropyridines; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Enalapril; Europe; Female; Follow-Up Studies; Heart Failure; Humans; Hydrochlorothiazide; Hypertension; Incidence; Linear Models; Male; Myocardial Infarction; Nitrendipine; Stroke; Survival Rate; Time Factors; Treatment Outcome | 2004 |
2 other study(ies) available for 1,4-dihydropyridine and Myocardial Infarction
| Article | Year |
|---|---|
Toward Second-Generation Cardiomyogenic and Anti-cardiofibrotic 1,4-Dihydropyridine-Class TGFβ Inhibitors.
Topics: Animals; Cell Differentiation; Dihydropyridines; Drug Design; Humans; Induced Pluripotent Stem Cells; Myocardial Infarction; Myocytes, Cardiac; Rats; Receptors, Transforming Growth Factor beta; Smad Proteins; Solubility; Structure-Activity Relationship; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta | 2019 |
Effects of long-acting versus short-acting calcium channel blockers among older survivors of acute myocardial infarction.
Topics: Aged; Calcium Channel Blockers; Dihydropyridines; Diltiazem; Female; Humans; Male; Myocardial Infarction; Nicardipine; Nifedipine; Proportional Hazards Models; Retrospective Studies; Risk; Survival Analysis; Survivors; Verapamil | 1999 |